×

Important Bioprocessing Summit Europe Update

In light of evolving updates and concerns around the coronavirus, we’ve decided to reschedule Bioprocessing Summit Europe to 21-23 July 2020. These new dates provide us the opportunity to deliver the quality event that you expect from CHI, and a safe environment for our attendees, speakers, sponsors, exhibitors, and staff. Over the coming days, we will be working with all our stakeholders to ensure continuity for the event and will share more information with you as it becomes available.

COVID-19 Updates & FAQ

PLENARY KEYNOTE SPEAKERS


Diane Blumenthal, PhD

Gene Therapy Manufacturing and Technical Development

Diane Blumenthal, PhD
Head, Technical Development, Spark Therapeutics

Ralf Schumacher, PhD

Current Opportunities and Challenges in Biotherapeutic CMC

Ralf Schumacher, PhD
Global Head, Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG



KEYNOTE SPEAKERS


Gerald Gellermann, PhD

Gerald Gellermann, PhD
Senior Fellow, Analytical Development, Novartis

Nicolas P. Mermod, PhD

Nicolas P. Mermod, PhD
Professor & Director, Biology & Medicine, University of Lausanne

Massimo Morbidelli, PhD

Massimo Morbidelli, PhD
Professor, Chemical and Bioengineering, ETH Zurich

Florence Salmon, PhD

Florence Salmon, PhD
Portfolio Lead Regulatory Affairs CMC, Cell and Gene Therapies, Novartis Pharma AG

Schmidt_Stefan

Stefan R. Schmidt, PhD
MBA, COO, Head, Operations, BioAtrium AG

Riccardo Torosantucci, PhD

Riccardo Torosantucci, PhD
Section Head, Formulation and Process Development, Sanofi-Aventis

Anne Tscheließnig, PhD

Anne Tscheließnig, PhD
Head, Downstream Development II, Biopharma Process Science Austria, Boehringer Ingelheim

James Warren, PhD

James Warren, PhD
Vice President, Pharmaceutical Development, Ultragenyx



Premier Sponsors






Join The Community at Bioprocessing Summit Europe


View prospectus & attendee breakdown
View details

Hear industry updates straight from bioprocess innovators
Learn more